Navigation Links
Early Morning Colonoscopies May Find More Polyps
Date:11/6/2009

Study suggests differences in patient preparation and doctor fatigue play a role,,

FRIDAY, Nov. 6 (HealthDay News) -- Early morning colonoscopies detect more polyps than colon cancer screenings done later in the day, and the number of polyps found decreases by the hour as the day progresses, a new study has found.

Removing polyps is believed to reduce the risk of colon cancer by 60 to 90 percent.

Researchers from the University of California, Los Angeles, analyzed data on 477 people who had colonoscopies in a one-year span at a Veterans Affairs hospital. Colonoscopies that started at 8:30 a.m. or earlier detected 27 percent more polyps per patient than colonoscopies performed at a later time, according to the study.

The improved rate in the early morning may be due to improved bowel preparation the night before, according to the researchers. They also suggested that doctor fatigue might also play a role in declining detection as the day wears on.

"We may find that setting a cap on the duration of endoscopic work shifts or other types of adjustments may be helpful," Dr. Brennan M.R. Spiegel, director of the UCLA/Veterans Affairs Center for Outcomes Research and Education and a co-author of the study, said in a UCLA news release.

He emphasized that colonoscopy is an effective way to screen for colon cancer at any time of the day and said that people should not worry about getting early morning procedures.

"The impact of appointment time for any individual is very, very small," Spiegel said. "Patients should feel confident that colonoscopy is helpful regardless of time of day and should be more focused on the quality and experience of their doctor rather than the time of their appointment."

The study is in the November issue of Clinical Gastroenterology and Hepatology.

More information

The U.S. National Institute of Diabetes and Digestive and K
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Approved lymphoma drug shows promise in early tests against bone cancer
2. Omnicare Pays Nearly $100 Million to Resolve Medicaid Fraud Charges: Second Omnicare Settlement With Chicago Whistleblower Pharmacist
3. Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
4. Nearly half of all US children will use food stamps, says poverty expert at WUSTL
5. Syphilis survey reveals need for accurate testing for early infection
6. Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant
7. Indiana Home Health Agency Pays Nearly $2 Million to Settle False Claims Act Allegations
8. Clearlycontacts.Ca Named as One of Bc's Top Employers
9. Skin cells may provide early warning for cancer risk elsewhere in body
10. FSU researcher wins $2.4M in grants to pursue early detection of autism
11. Renowned Southern California Doctors Emphasizing Early Detection During Breast Cancer Awareness Month

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...EINE, France, Nov. 27 Team Garmin-...g team dedicated to ethical sporting and developin...ced today that it will become Team Garmin-Transiti...new sponsor of the team. Transitions Optical is th..., offering the most advanced photochromic technolo...
(Date:11/27/2009)... SEATTLE, Nov. 27 Allrecipes.com ... Thanksgiving traffic numbers, with more than 2.8 ...iding a clear picture of what was served on the bi...giving meal in 2009 weighed in at 2,225 calories p...feast. According to the Allrecipes site, Sweet Po...
(Date:11/26/2009)...27 With cold and flu season upon u...actices to control the spread of infections and av...ly to keep ourselves healthy, but to avoid transmi... RN, MS, CIC (certified in infection-control), nur...al health at Hospital for Special Surgery (HSS) in...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...nnis & Ennis, P.A. is offering free nationwide...asmin birth control pills who have suffered a Deep..., Heart Attack or other related cardiac issues or ... free at 1-800-856-6405 or go to the firm’s ...an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...s using assisted reproductive technology should be...Y, May 20 (HealthDay News) -- Compared to naturall...d reproductive technology (ART) are more likely to...n in Western Australia between 1994 and 2000. , "W...
...NGSTON, N.J., May 21 Milestone Scientific Inc. (O... advanced injection technologies, today announced ...heduled to be held on Thursday, June 4, 2009 begin... Brown, Rudnick, Berlack and Israels located at 7 ...
...VEGAS, May 21 CPC of America, Inc. (OTC Bulletin ... first patent of a synthetic sealant for specific ...ed on the development and testing of the MedClose(...C is focused on the development of its own synthet...
...TON, May 21 Stem Cell Innovations, (Pink Sheets: ...he only products on the market using a standardize...cities associated with nutraceuticals and dietary ...ing system could help prevent recalls associated w...
...Athletes Use Energy Muse Jewelry As Their Lucky Ch...t the skip in their step and the twinkle in their ...wn Johnson and partner Mark Ballas on Season 8 fin...ity -- during the last two weeks of the competitio...
...nts Optimize Resources With Imaging, Behavioral an... Delivering efficient, high-quality healthcare is...ality and workflow tools embedded in the new Mill...delines, workflow by mapping its clinical content...
Other Medicine News:Health News:Fertility Treatment Twins More at Risk for Hospitalizations 2Health News:Milestone Scientific to Host 2009 Annual Meeting of Stockholders on Thursday, June 4, 2009 in New York City 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 2Health News:CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS) 3Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 2Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 3Health News:Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 3
(Date:11/26/2009)...HANNESBURG, South Africa, Nov. 26 ... of the Year Award in the Generic Pharmaceutical M...mited. ,, (Logo: http://www.newscom.com/cgi-bi...the Year Award, the following criteria were used t... competitors: growth strategy and implementation, ...
(Date:11/25/2009)...ETON, N.J., Nov. 25 Phar...armaceutical company committed to discovering, dev...iral infections, reported financial results for th...er 30, 2009 Pharmasset held $58.4 million in cash,..., Pipeline Update and 2009 Highlights ,, RG...
(Date:11/25/2009)... PALM BEACH, Fla., Nov. 25 /PRNewswire-FirstCall/ ...ericans, especially the 27 million living with unt... that happy, says audiologist Cindy Beyer. ,, D... EAR ), one of America,s largest hearing care and ... hearing loss to stress, frustration, and social i...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 1Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 2Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 1QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 2QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 3QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 4QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 5QLT announces 12 month results from Novartis sponsored MONT BLANC study evaluating standard fluence Visudyne 28R 29 combination therapy 48853 6AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 1AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 2AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 3AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 4AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 12614 5
...ation aimed at enabling vaccine production facilit...itional egg-based facility., * Once established, ...of, pandemic flu vaccine to commence within 12 we...ngland and ROCKVILLE, Md., Dec. 10, GE Healthcare,...and Novavax Inc. (Nasdaq: NVAX ), today announced...
...ec. 10 Exelixis, Inc. (Nasdaq:,EXEL), today repor...XL019,in patients with myelofibrosis, a myeloproli...al small molecule that selectively inhibits the ty... activated in response to,cytokines and hematopoie...ted in the majority of MPD patients and is deregul...
Other Medicine Technology:GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 2Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 3Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: